Stay updated on LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.3 on the Study Record History page, replacing the previous v3.6.2. This indicates a minor page revision in the site's revision history interface.
    Difference
    0.1%
    Check dated 2026-07-04T08:19:22.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 appears in the record history, replacing v3.6.0. This marks a minor platform/format update to the page's history display with no changes to the study data or trial details.
    Difference
    0.1%
    Check dated 2026-06-27T06:19:07.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The history now shows recruitment is closed (no longer looking for participants). The revision note was updated to v3.6.0, replacing the previous v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-13T00:31:48.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new revision tag, v3.5.5, has been added to the record history, replacing the previous v3.5.4. This indicates an update to the page's revision documentation without altering study data or content.
    Difference
    0.1%
    Check dated 2026-06-05T22:12:34.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The study record history shows a new revision labeled v3.5.4 as the latest version, while the prior v3.5.3 label is no longer listed.
    Difference
    0.1%
    Check dated 2026-05-15T06:57:14.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page’s displayed software/UI revision label changes from v3.5.2 to v3.5.3, indicating a general platform update without altering the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:36.000Z thumbnail image

Stay in the know with updates to LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.